Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants
- PMID: 8096235
- PMCID: PMC2190981
- DOI: 10.1084/jem.177.4.1021
Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants
Abstract
Human lymphoblastoid cells transiently expressing the hemagglutinin (HA) glycoprotein of influenza virus are rapidly and efficiently recognized by CD4+ HA-specific T lymphocytes. This endogenous presentation pathway is sensitive to chloroquine and is therefore likely related to the classical class II major histocompatibility complex (MHC) exogenous pathway of antigen presentation. In this study we have examined a series of transport-defective HA mutants. We correlate the intracellular fate of the native antigen with its presentation characteristics. We have found that the native antigen must enter the secretory pathway since a cytosolic form is not presented. However, surface expression and normal trafficking through the Golgi apparatus are not required for efficient presentation. Instead, escape of native antigen from the endoplasmic reticulum appears to be both necessary and sufficient for gaining access to a compartment where antigen is processed and binds class II MHC molecules.
Similar articles
-
The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen.J Immunol. 1990 Apr 1;144(7):2789-94. J Immunol. 1990. PMID: 1690778
-
Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.Eur J Immunol. 1993 Nov;23(11):2746-50. doi: 10.1002/eji.1830231104. Eur J Immunol. 1993. PMID: 8223850
-
Class II MHC molecules can use the endogenous pathway of antigen presentation.Nature. 1990 Jan 4;343(6253):74-6. doi: 10.1038/343074a0. Nature. 1990. PMID: 1967486
-
Peripheral tolerance in transgenic mice: tolerance to class II MHC and non-MHC transgene antigens.Immunol Rev. 1991 Aug;122:87-102. doi: 10.1111/j.1600-065x.1991.tb00598.x. Immunol Rev. 1991. PMID: 1682240 Review. No abstract available.
-
Virus entry and antigen biosynthesis in the processing and presentation of class-II MHC-restricted T-cell determinants of influenza virus.Immunol Res. 1990;9(2):103-14. doi: 10.1007/BF02918201. Immunol Res. 1990. PMID: 2140852 Review.
Cited by
-
Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen.Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14692-7. doi: 10.1073/pnas.93.25.14692. Proc Natl Acad Sci U S A. 1996. PMID: 8962116 Free PMC article.
-
Virus-specific CD4+ T cells: ready for direct attack.J Exp Med. 2006 Apr 17;203(4):805-8. doi: 10.1084/jem.20060215. Epub 2006 Mar 20. J Exp Med. 2006. PMID: 16549599 Free PMC article. Review.
-
Diversity in MHC class II antigen presentation.Immunology. 2002 Mar;105(3):252-62. doi: 10.1046/j.0019-2805.2001.01358.x. Immunology. 2002. PMID: 11918686 Free PMC article. Review.
-
A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.J Exp Med. 1994 Feb 1;179(2):541-9. doi: 10.1084/jem.179.2.541. J Exp Med. 1994. PMID: 8294865 Free PMC article.
-
Targeted Alteration of Antibody-Based Immunodominance Enhances the Heterosubtypic Immunity of an Experimental PCV2 Vaccine.Vaccines (Basel). 2020 Sep 4;8(3):506. doi: 10.3390/vaccines8030506. Vaccines (Basel). 2020. PMID: 32899842 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials